Laplace Interventional™ Announces First Patients treated in TRIUMPH Pivotal Trial with its Transcatheter Tricuspid Valve Replacement System

Barchart · 3d ago

PLYMOUTH, Minn., Oct. 29, 2026 /PRNewswire/ -- Minnesota based Laplace Interventional today announced that the first three patients have been enrolled and treated in the randomized cohort of their TRIUMPH pivotal trial. These patients were treated at Ballad Health (Kingsport, TN) and Oklahoma Heart Institute (Tulsa, OK) by structural heart teams headed by Dr. Gaurav Rana, MD, Interventional Cardiologist at Ballad Health and Dr. Kamran Muhammad, MD, Director of Structural Heart Program at Oklahoma Heart Institute respectively.

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.